Advisory Services Network’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Hold
0
-$22 3737
2023
Q4
Hold
0
3835
2023
Q2
Hold
0
-$37 3739
2023
Q1
Sell
-1
Closed -$86 3934
2022
Q4
$58 Buy
+1
New +$55 ﹤0.01% 3933
2021
Q4
Sell
-155
Closed -$16K 1525
2021
Q3
$16K Hold
155
﹤0.01% 1374
2021
Q2
$18K Hold
155
﹤0.01% 2555
2021
Q1
$19K Buy
155
+123
+384% +$17.2K ﹤0.01% 1275
2020
Q4
$3K Buy
32
+31
+3,100% +$3.66K ﹤0.01% 2945
2020
Q3
$0 Buy
+1
New +$208 ﹤0.01% 3662
2020
Q2
Sell
-1
Closed 2797
2020
Q1
$0 Buy
+1
New +$331 ﹤0.01% 3319

Other funds holding QNTM

Advisory Services Network's QNTM Position: Q1 2024 in Review

Advisory Services Network held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3737.

Advisory Services Network first reported a position in QNTM in Q1 2020 and has held it in 7 quarters since. The position peaked at $19K in Q1 2021. 11 funds tracked by Wall St. Rank hold QNTM as of Q1 2024.

  • Advisory Services Network held 0 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $0 as of Q1 2024.
  • Advisory Services Network left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q1 2024.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2024, its #3737 holding.
  • Advisory Services Network first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2020 and has held it in 7 quarters since.
  • Advisory Services Network's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $19K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.